{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:40:47Z","timestamp":1791776447684,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation and Entrepreneurship Training Program for College Students","award":["202412631029"],"award-info":[{"award-number":["202412631029"]}]},{"name":"Xiamen Medical and Health Guidance Project","award":["3502Z20244ZD1155"],"award-info":[{"award-number":["3502Z20244ZD1155"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2024J011399"],"award-info":[{"award-number":["2024J011399"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xiamen Medical College School-Hospital Joint Funding Project","award":["K2023-03"],"award-info":[{"award-number":["K2023-03"]}]},{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2024Y9724"],"award-info":[{"award-number":["2024Y9724"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03818-z","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:06:50Z","timestamp":1761559610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["GNPNAT1 acts as a prognostic biomarker associated with immune infiltration in lung adenocarcinoma and promotes the proliferation and invasion of cancer cells"],"prefix":"10.1007","volume":"16","author":[{"given":"Qingfeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meigui","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"3","key":"3818_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3818_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, et al. Cancer statistics in China and united States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"key":"3818_CR3","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","volume":"1","author":"C Gridelli","year":"2015","unstructured":"Gridelli C, Rossi A, Carbone DP, et al. Non-small-cell lung cancer. Nat Rev Dis Primers. 2015;1:15009.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3818_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.","journal-title":"Nat Commun"},{"issue":"4","key":"3818_CR5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/ijms19041259","volume":"19","author":"K Inamura","year":"2018","unstructured":"Inamura K. Clinicopathological characteristics and mutations driving development of early lung adenocarcinoma: tumor initiation and progression. Int J Mol Sci. 2018;19(4):1259.","journal-title":"Int J Mol Sci"},{"issue":"7689","key":"3818_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"9","key":"3818_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","volume":"19","author":"F Skoulidis","year":"2019","unstructured":"Skoulidis F, Heymach JV. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat Rev Cancer. 2019;19(9):495\u2013509.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3818_CR8","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. CA Cancer J Clin 2024 Jan-Feb. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin 2024 Jan-Feb"},{"issue":"6","key":"3818_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DSW. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations. J Clin Oncol. 2022;40(6):611\u201325.","journal-title":"J Clin Oncol"},{"key":"3818_CR10","doi-asserted-by":"publisher","first-page":"823618","DOI":"10.3389\/fimmu.2022.823618","volume":"13","author":"H Mamdani","year":"2022","unstructured":"Mamdani H, Matosevic S, Khalid AB, et al. Immunotherapy in lung cancer: current landscape and future directions. Front Immunol. 2022;13:823618.","journal-title":"Front Immunol"},{"issue":"17","key":"3818_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1200\/JCO.2017.77.0412","volume":"36","author":"S Gettinger","year":"2018","unstructured":"Gettinger S, Horn L, Jackman D, et al. Five-Year Follow-Up of nivolumab in previously treated advanced Non-Small-Cell lung cancer: results from the CA209-003 study. J Clin Oncol. 2018;36(17):1675\u201384.","journal-title":"J Clin Oncol"},{"issue":"20","key":"3818_CR12","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1016\/j.febslet.2008.07.040","volume":"582","author":"J Wang","year":"2008","unstructured":"Wang J, Liu X, Liang YH, et al. Acceptor substrate binding revealed by crystal structure of human glucosamine-6-phosphate N-acetyltransferase 1. FEBS Lett. 2008;582(20):2973\u20138.","journal-title":"FEBS Lett"},{"issue":"1","key":"3818_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1074\/jbc.274.1.424","volume":"274","author":"T Mio","year":"1999","unstructured":"Mio T, Yamada-Okabe T, Arisawa M, et al. Saccharomyces cerevisiae GNA1, an essential gene encoding a novel acetyltransferase involved in UDP-N-acetylglucosamine synthesis. J Biol Chem. 1999;274(1):424\u20139.","journal-title":"J Biol Chem"},{"key":"3818_CR14","doi-asserted-by":"crossref","unstructured":"Singh JP, Zhang K, Wu J, et al. O-GlcNAc signaling in cancer metabolism and epigenetics. Cancer Lett. 2015;356(2 Pt A):244\u2013\u200950.","DOI":"10.1016\/j.canlet.2014.04.014"},{"issue":"4","key":"3818_CR15","doi-asserted-by":"publisher","first-page":"1601734","DOI":"10.1183\/13993003.01734-2016","volume":"49","author":"O Calvayrac","year":"2017","unstructured":"Calvayrac O, Pradines A, Pons E, et al. Molecular biomarkers for lung adenocarcinoma. Eur Respir J. 2017;49(4):1601734.","journal-title":"Eur Respir J"},{"issue":"50","key":"3818_CR16","doi-asserted-by":"publisher","first-page":"34457","DOI":"10.1074\/jbc.R114.577718","volume":"289","author":"Z Ma","year":"2014","unstructured":"Ma Z, Vosseller K. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling. J Biol Chem. 2014;289(50):34457\u201365.","journal-title":"J Biol Chem"},{"issue":"7433","key":"3818_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature11742","volume":"493","author":"Q Chen","year":"2013","unstructured":"Chen Q, Chen Y, Bian C, Fujiki R, et al. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature. 2013;493(7433):561\u20134.","journal-title":"Nature"},{"key":"3818_CR18","doi-asserted-by":"publisher","first-page":"1152678","DOI":"10.3389\/fimmu.2023.1152678","volume":"14","author":"R Yuan","year":"2023","unstructured":"Yuan R, Zhang Y, Wang Y, et al. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer. Front Immunol. 2023;14:1152678.","journal-title":"Front Immunol"},{"issue":"2","key":"3818_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3892\/or.2023.8594","volume":"50","author":"H Hu","year":"2023","unstructured":"Hu H, Wang ZW, Hu S, et al. GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker. Oncol Rep. 2023;50(2):157.","journal-title":"Oncol Rep"},{"key":"3818_CR20","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.1038\/ncomms11612","volume":"7","author":"AK Kaushik","year":"2016","unstructured":"Kaushik AK, Shojaie A, Panzitt K, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016;7:11612.","journal-title":"Nat Commun"},{"issue":"5","key":"3818_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"key":"3818_CR22","doi-asserted-by":"publisher","first-page":"12632","DOI":"10.1038\/ncomms12632","volume":"7","author":"CW Li","year":"2016","unstructured":"Li CW, Lim SO, Xia W, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7:12632.","journal-title":"Nat Commun"},{"issue":"4","key":"3818_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"TM Malta","year":"2018","unstructured":"Malta TM, Noushmehr H, Pedamallu CS, et al. The immune landscape of cancer. Immunity. 2018;48(4):812\u2013e83014.","journal-title":"Immunity"},{"key":"3818_CR24","doi-asserted-by":"publisher","first-page":"e2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen M, Zhang C, Lee S, Sj\u00f6stedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:e2507.","journal-title":"Science"},{"key":"3818_CR25","doi-asserted-by":"publisher","first-page":"e3321","DOI":"10.1126\/science.aal3321","volume":"356","author":"PJ Thul","year":"2017","unstructured":"Thul PJ, \u00c5kesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, Alm T, Asplund A, Bj\u00f6rk L, Breckels LM, et al. A subcellular map of the human proteome. Science. 2017;356:e3321.","journal-title":"Science"},{"key":"3818_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitat- Ing tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358.","journal-title":"Neoplasia"},{"key":"3818_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of Survival-Associated genes in solid tumors. Innov. 2024. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625.","journal-title":"Innov"},{"issue":"D1","key":"3818_CR28","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al. ).CancerSEA: A cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138. https:\/\/doi.org\/10.1093\/nar\/gky939.","journal-title":"Nucleic Acids Res"},{"key":"3818_CR29","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multiomics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956\u201363.","journal-title":"Nucleic Acids Res"},{"key":"3818_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. ClusterProfler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"issue":"1","key":"3818_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1158\/2159-8290.CD-20-0142","volume":"11","author":"MH Hofmann","year":"2021","unstructured":"Hofmann MH, Gmachl M, Ramharter J, et al. BI-3406, a potent and selective SOS1-KRAS interaction Inhibitor, is effective in KRAS-Driven cancers through combined MEK Inhibition. Cancer Discov. 2021;11(1):142\u201357.","journal-title":"Cancer Discov"},{"issue":"17","key":"3818_CR32","doi-asserted-by":"publisher","first-page":"12821","DOI":"10.1074\/jbc.275.17.12821","volume":"275","author":"G Boehmelt","year":"2000","unstructured":"Boehmelt G, Fialka I, Brothers G, et al. Cloning and characterization of the murine glucosamine-6-phosphate acetyltransferase EMeg32. Differential expression and intracellular membrane association. J Biol Chem. 2000;275(17):12821\u201332.","journal-title":"J Biol Chem"},{"issue":"2","key":"3818_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1139\/bcb-2015-0115","volume":"94","author":"I Brockhausen","year":"2016","unstructured":"Brockhausen I, Nair DG, Chen M, et al. Human acetyl-CoA:glucosamine-6-phosphate N-acetyltransferase 1 has a relaxed donor specificity and transfers acyl groups up to four carbons in length. Biochem Cell Biol. 2016;94(2):197\u2013204.","journal-title":"Biochem Cell Biol"},{"key":"3818_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1146\/annurev.biochem.73.011303.073752","volume":"73","author":"A Helenius","year":"2004","unstructured":"Helenius A, Aebi M. Roles of N-linked glycans in the Endoplasmic reticulum. Annu Rev Biochem. 2004;73:1019\u201349.","journal-title":"Annu Rev Biochem"},{"issue":"Pt 3","key":"3818_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1042\/bj3500815","volume":"350","author":"Z Kostova","year":"2000","unstructured":"Kostova Z, Rancour DM, Menon AK, et al. Photoaffinity labelling with P3-(4-azidoanilido)uridine 5\u2019-triphosphate identifies gpi3p as the UDP-GlcNAc-binding subunit of the enzyme that catalyses formation of GlcNAc-phosphatidylinositol, the first glycolipid intermediate in glycosylphosphatidylinositol synthesis. Biochem J. 2000;350(Pt 3):815\u201322.","journal-title":"Biochem J"},{"key":"3818_CR36","doi-asserted-by":"publisher","first-page":"605754","DOI":"10.3389\/fmolb.2021.605754","volume":"8","author":"W Liu","year":"2021","unstructured":"Liu W, Jiang K, Wang J, et al. Upregulation of GNPNAT1 predicts poor prognosis and correlates with immune infiltration in lung adenocarcinoma. Front Mol Biosci. 2021;8:605754.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"3818_CR37","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.18632\/aging.202604","volume":"13","author":"S Zhang","year":"2021","unstructured":"Zhang S, Zhang H, Li H, et al. Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma. Aging. 2021;13(5):7430\u201353.","journal-title":"Aging"},{"key":"3818_CR38","doi-asserted-by":"publisher","first-page":"8851437","DOI":"10.1155\/2020\/8851437","volume":"2020","author":"X Zheng","year":"2020","unstructured":"Zheng X, Li Y, Ma C, et al. Independent prognostic potential of GNPNAT1 in lung adenocarcinoma. Biomed Res Int. 2020;2020:8851437.","journal-title":"Biomed Res Int"},{"key":"3818_CR39","doi-asserted-by":"publisher","first-page":"5310793","DOI":"10.1155\/2020\/5310793","volume":"2020","author":"X Yu","year":"2020","unstructured":"Yu X, Zhang X, Zhang Y. Identification of a 5-Gene metabolic signature for predicting prognosis based on an integrated analysis of tumor microenvironment in lung adenocarcinoma. J Oncol. 2020;2020:5310793.","journal-title":"J Oncol"},{"issue":"2","key":"3818_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41416-022-02056-2","volume":"128","author":"D Jacenik","year":"2023","unstructured":"Jacenik D, Karagiannidis I, Beswick EJ. Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils. Br J Cancer. 2023;128(2):387\u201397.","journal-title":"Br J Cancer"},{"issue":"9","key":"3818_CR41","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Han X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest. 2015;125(9):3384\u201391.","journal-title":"J Clin Invest"},{"issue":"3","key":"3818_CR42","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, et al. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997\u20132007.","journal-title":"Exp Ther Med"},{"issue":"2","key":"3818_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/path.5246","volume":"248","author":"S Wang","year":"2019","unstructured":"Wang S, Wang X, Gao Y, et al. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK\/MAPK-cyclin D1\/CDK4 pathway. J Pathol. 2019;248(2):204\u201316.","journal-title":"J Pathol"},{"issue":"7","key":"3818_CR44","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1158\/1535-7163.MCT-13-0938","volume":"13","author":"R Parker","year":"2014","unstructured":"Parker R, Clifton-Bligh R, Molloy MP. Phosphoproteomics of MAPK Inhibition in BRAF-mutated cells and a role for the lethal synergism of dual BRAF and CK2 Inhibition. Mol Cancer Ther. 2014;13(7):1894\u2013906.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"3818_CR45","first-page":"585","volume":"48","author":"CH Lee","year":"1999","unstructured":"Lee CH, Yun HJ, Kang HS, et al. ERK\/MAPK pathway is required for changes of Cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells. IUBMB Life. 1999;48(6):585\u201391.","journal-title":"IUBMB Life"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03818-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03818-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03818-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:08:15Z","timestamp":1761847695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03818-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3818"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03818-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human participants, human data or human tissues. It only includes bioinformatics analysis and cell experiments, and therefore does not require ethical approval or consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Every author on the list has had an active part in the research and has reviewed and approved the completed publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1966"}}